0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sumatriptan Subcutaneous Injection Market Research Report 2026
Published Date: 2026-03-20
|
Report Code: QYRE-Auto-22D20138
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Sumatriptan Subcutaneous Injection Market Research Report 2026
BUY CHAPTERS

Global Sumatriptan Subcutaneous Injection Market Research Report 2026

Code: QYRE-Auto-22D20138
Report
2026-03-20
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sumatriptan Subcutaneous Injection Market Size

The global Sumatriptan Subcutaneous Injection market was valued at US$ 176 million in 2025 and is anticipated to reach US$ 241 million by 2032, at a CAGR of 4.6% from 2026 to 2032.

Sumatriptan Subcutaneous Injection Market

Sumatriptan Subcutaneous Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sumatriptan Subcutaneous Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Sumatriptan Subcutaneous Injection is an injectable formulation of a triptan-class 5-HT1B/1D receptor agonist, primarily indicated for the rapid relief of acute migraine attacks in adults and, in selected cases, cluster headache. It is characterized by fast onset of action and rapid achievement of peak plasma concentration, and is commonly supplied as a 6 mg/0.5 mL prefilled syringe or auto-injector device. Upstream raw materials mainly include sumatriptan succinate active pharmaceutical ingredient (API), sterile water for injection, buffering systems such as acetate or phosphate buffers, stabilizers, and device components for prefilled syringes (glass barrel, rubber stopper, needle assembly) or auto-injector systems. Manufacturing involves aseptic compounding, sterile filtration, filling, and either terminal sterilization or fully aseptic processing under stringent cleanroom and GMP standards. Downstream customers include global and regional generic pharmaceutical manufacturers, hospital emergency departments and neurology clinics, specialty practices, and retail pharmacy channels. On a manufacturing ex-factory basis, global nominal capacity in 2025 is estimated at approximately 7.8 million units, with actual sales of about 7.12 million units and a weighted average ex-factory price of around USD 24.7 per unit; under conditions of generic competition and the relatively higher production costs of sterile injectables, manufacturing-level gross margin typically ranges from 32% to 42%.
The North American market for Sumatriptan Subcutaneous Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Sumatriptan Subcutaneous Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Sumatriptan Subcutaneous Injection include GlaxoSmithKline, Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Lupin Laboratories, Prasco Laboratories, Sawai Pharmaceutical, Aurobindo Pharma, Teva Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Sumatriptan Subcutaneous Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sumatriptan Subcutaneous Injection. The Sumatriptan Subcutaneous Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sumatriptan Subcutaneous Injection market comprehensively. Regional market sizes by Type, by Application, by Dose Strength, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sumatriptan Subcutaneous Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Sumatriptan Subcutaneous Injection Market Report

Report Metric Details
Report Name Sumatriptan Subcutaneous Injection Market
Accounted market size in 2025 US$ 176 million
Forecasted market size in 2032 US$ 241 million
CAGR 4.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Prefilled Syringe
  • Auto-injector Device
  • Others
Segment by Dose Strength
  • 6 mg / 0.5 mL
  • 3 mg / 0.5 mL
by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Lupin Laboratories, Prasco Laboratories, Sawai Pharmaceutical, Aurobindo Pharma, Teva Pharmaceutical Industries
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Dose Strength, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Sumatriptan Subcutaneous Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Sumatriptan Subcutaneous Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Sumatriptan Subcutaneous Injection Market growing?

Ans: The Sumatriptan Subcutaneous Injection Market witnessing a CAGR of 4.6% during the forecast period 2026-2032.

What is the Sumatriptan Subcutaneous Injection Market size in 2032?

Ans: The Sumatriptan Subcutaneous Injection Market size in 2032 will be US$ 241 million.

Who are the main players in the Sumatriptan Subcutaneous Injection Market report?

Ans: The main players in the Sumatriptan Subcutaneous Injection Market are GlaxoSmithKline, Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Lupin Laboratories, Prasco Laboratories, Sawai Pharmaceutical, Aurobindo Pharma, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Sumatriptan Subcutaneous Injection Market report?

Ans: The Applications covered in the Sumatriptan Subcutaneous Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Sumatriptan Subcutaneous Injection Market report?

Ans: The Types covered in the Sumatriptan Subcutaneous Injection Market report are Prefilled Syringe, Auto-injector Device, Others

1 Sumatriptan Subcutaneous Injection Market Overview
1.1 Product Definition
1.2 Sumatriptan Subcutaneous Injection by Type
1.2.1 Global Sumatriptan Subcutaneous Injection Market Value by Type: 2025 vs 2032
1.2.2 Prefilled Syringe
1.2.3 Auto-injector Device
1.2.4 Others
1.3 Sumatriptan Subcutaneous Injection by Dose Strength
1.3.1 Global Sumatriptan Subcutaneous Injection Market Value by Dose Strength: 2025 vs 2032
1.3.2 6 mg / 0.5 mL
1.3.3 3 mg / 0.5 mL
1.4 Sumatriptan Subcutaneous Injection by Application
1.4.1 Global Sumatriptan Subcutaneous Injection Market Value by Application: 2025 vs 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Sumatriptan Subcutaneous Injection Market Size Estimates and Forecasts
1.5.1 Global Sumatriptan Subcutaneous Injection Revenue 2021–2032
1.5.2 Global Sumatriptan Subcutaneous Injection Sales 2021–2032
1.5.3 Global Sumatriptan Subcutaneous Injection Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Sumatriptan Subcutaneous Injection Market Competition by Manufacturers
2.1 Global Sumatriptan Subcutaneous Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Sumatriptan Subcutaneous Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Sumatriptan Subcutaneous Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Sumatriptan Subcutaneous Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Sumatriptan Subcutaneous Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Sumatriptan Subcutaneous Injection, Product Types and Applications
2.7 Global Key Manufacturers of Sumatriptan Subcutaneous Injection, Date of Entry into the Industry
2.8 Global Sumatriptan Subcutaneous Injection Market Competitive Situation and Trends
2.8.1 Global Sumatriptan Subcutaneous Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Sumatriptan Subcutaneous Injection Players Market Share by Revenue
2.8.3 Global Sumatriptan Subcutaneous Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sumatriptan Subcutaneous Injection Market Scenario by Region
3.1 Global Sumatriptan Subcutaneous Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Sumatriptan Subcutaneous Injection Sales by Region: 2021–2032
3.2.1 Global Sumatriptan Subcutaneous Injection Sales by Region: 2021–2026
3.2.2 Global Sumatriptan Subcutaneous Injection Sales by Region: 2027–2032
3.3 Global Sumatriptan Subcutaneous Injection Revenue by Region: 2021–2032
3.3.1 Global Sumatriptan Subcutaneous Injection Revenue by Region: 2021–2026
3.3.2 Global Sumatriptan Subcutaneous Injection Revenue by Region: 2027–2032
3.4 North America Sumatriptan Subcutaneous Injection Market Facts & Figures by Country
3.4.1 North America Sumatriptan Subcutaneous Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Sumatriptan Subcutaneous Injection Sales by Country (2021–2032)
3.4.3 North America Sumatriptan Subcutaneous Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sumatriptan Subcutaneous Injection Market Facts & Figures by Country
3.5.1 Europe Sumatriptan Subcutaneous Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Sumatriptan Subcutaneous Injection Sales by Country (2021–2032)
3.5.3 Europe Sumatriptan Subcutaneous Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sumatriptan Subcutaneous Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Sumatriptan Subcutaneous Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Sumatriptan Subcutaneous Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Sumatriptan Subcutaneous Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sumatriptan Subcutaneous Injection Market Facts & Figures by Country
3.7.1 Latin America Sumatriptan Subcutaneous Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Sumatriptan Subcutaneous Injection Sales by Country (2021–2032)
3.7.3 Latin America Sumatriptan Subcutaneous Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sumatriptan Subcutaneous Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Sumatriptan Subcutaneous Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Sumatriptan Subcutaneous Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Sumatriptan Subcutaneous Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sumatriptan Subcutaneous Injection Sales by Type (2021–2032)
4.1.1 Global Sumatriptan Subcutaneous Injection Sales by Type (2021–2026)
4.1.2 Global Sumatriptan Subcutaneous Injection Sales by Type (2027–2032)
4.1.3 Global Sumatriptan Subcutaneous Injection Sales Market Share by Type (2021–2032)
4.2 Global Sumatriptan Subcutaneous Injection Revenue by Type (2021–2032)
4.2.1 Global Sumatriptan Subcutaneous Injection Revenue by Type (2021–2026)
4.2.2 Global Sumatriptan Subcutaneous Injection Revenue by Type (2027–2032)
4.2.3 Global Sumatriptan Subcutaneous Injection Revenue Market Share by Type (2021–2032)
4.3 Global Sumatriptan Subcutaneous Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Sumatriptan Subcutaneous Injection Sales by Application (2021–2032)
5.1.1 Global Sumatriptan Subcutaneous Injection Sales by Application (2021–2026)
5.1.2 Global Sumatriptan Subcutaneous Injection Sales by Application (2027–2032)
5.1.3 Global Sumatriptan Subcutaneous Injection Sales Market Share by Application (2021–2032)
5.2 Global Sumatriptan Subcutaneous Injection Revenue by Application (2021–2032)
5.2.1 Global Sumatriptan Subcutaneous Injection Revenue by Application (2021–2026)
5.2.2 Global Sumatriptan Subcutaneous Injection Revenue by Application (2027–2032)
5.2.3 Global Sumatriptan Subcutaneous Injection Revenue Market Share by Application (2021–2032)
5.3 Global Sumatriptan Subcutaneous Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline Sumatriptan Subcutaneous Injection Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Dr Reddy's Laboratories
6.2.1 Dr Reddy's Laboratories Company Information
6.2.2 Dr Reddy's Laboratories Description and Business Overview
6.2.3 Dr Reddy's Laboratories Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Dr Reddy's Laboratories Sumatriptan Subcutaneous Injection Product Portfolio
6.2.5 Dr Reddy's Laboratories Recent Developments/Updates
6.3 Sun Pharmaceutical Industries
6.3.1 Sun Pharmaceutical Industries Company Information
6.3.2 Sun Pharmaceutical Industries Description and Business Overview
6.3.3 Sun Pharmaceutical Industries Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sun Pharmaceutical Industries Sumatriptan Subcutaneous Injection Product Portfolio
6.3.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.4 Lupin Laboratories
6.4.1 Lupin Laboratories Company Information
6.4.2 Lupin Laboratories Description and Business Overview
6.4.3 Lupin Laboratories Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Lupin Laboratories Sumatriptan Subcutaneous Injection Product Portfolio
6.4.5 Lupin Laboratories Recent Developments/Updates
6.5 Prasco Laboratories
6.5.1 Prasco Laboratories Company Information
6.5.2 Prasco Laboratories Description and Business Overview
6.5.3 Prasco Laboratories Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Prasco Laboratories Sumatriptan Subcutaneous Injection Product Portfolio
6.5.5 Prasco Laboratories Recent Developments/Updates
6.6 Sawai Pharmaceutical
6.6.1 Sawai Pharmaceutical Company Information
6.6.2 Sawai Pharmaceutical Description and Business Overview
6.6.3 Sawai Pharmaceutical Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sawai Pharmaceutical Sumatriptan Subcutaneous Injection Product Portfolio
6.6.5 Sawai Pharmaceutical Recent Developments/Updates
6.7 Aurobindo Pharma
6.7.1 Aurobindo Pharma Company Information
6.7.2 Aurobindo Pharma Description and Business Overview
6.7.3 Aurobindo Pharma Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Aurobindo Pharma Sumatriptan Subcutaneous Injection Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Teva Pharmaceutical Industries
6.8.1 Teva Pharmaceutical Industries Company Information
6.8.2 Teva Pharmaceutical Industries Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Sumatriptan Subcutaneous Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Teva Pharmaceutical Industries Sumatriptan Subcutaneous Injection Product Portfolio
6.8.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sumatriptan Subcutaneous Injection Industry Chain Analysis
7.2 Sumatriptan Subcutaneous Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sumatriptan Subcutaneous Injection Production Mode & Process Analysis
7.4 Sumatriptan Subcutaneous Injection Sales and Marketing
7.4.1 Sumatriptan Subcutaneous Injection Sales Channels
7.4.2 Sumatriptan Subcutaneous Injection Distributors
7.5 Sumatriptan Subcutaneous Injection Customer Analysis
8 Sumatriptan Subcutaneous Injection Market Dynamics
8.1 Sumatriptan Subcutaneous Injection Industry Trends
8.2 Sumatriptan Subcutaneous Injection Market Drivers
8.3 Sumatriptan Subcutaneous Injection Market Challenges
8.4 Sumatriptan Subcutaneous Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sumatriptan Subcutaneous Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Sumatriptan Subcutaneous Injection Market Value by Dose Strength (US$ Million), 2025 vs 2032
 Table 3. Global Sumatriptan Subcutaneous Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Sumatriptan Subcutaneous Injection Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Sumatriptan Subcutaneous Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 6. Global Sumatriptan Subcutaneous Injection Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Sumatriptan Subcutaneous Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Sumatriptan Subcutaneous Injection Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Sumatriptan Subcutaneous Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Sumatriptan Subcutaneous Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Sumatriptan Subcutaneous Injection, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Sumatriptan Subcutaneous Injection, Product Types and Applications
 Table 13. Global Key Manufacturers of Sumatriptan Subcutaneous Injection, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Sumatriptan Subcutaneous Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sumatriptan Subcutaneous Injection Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Sumatriptan Subcutaneous Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Sumatriptan Subcutaneous Injection Sales by Region (K Units), 2021–2026
 Table 19. Global Sumatriptan Subcutaneous Injection Sales Market Share by Region (2021–2026)
 Table 20. Global Sumatriptan Subcutaneous Injection Sales by Region (K Units), 2027–2032
 Table 21. Global Sumatriptan Subcutaneous Injection Sales Market Share by Region (2027–2032)
 Table 22. Global Sumatriptan Subcutaneous Injection Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Sumatriptan Subcutaneous Injection Revenue Market Share by Region (2021–2026)
 Table 24. Global Sumatriptan Subcutaneous Injection Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Sumatriptan Subcutaneous Injection Revenue Market Share by Region (2027–2032)
 Table 26. North America Sumatriptan Subcutaneous Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2021–2026
 Table 28. North America Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2027–2032
 Table 29. North America Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Sumatriptan Subcutaneous Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2021–2026
 Table 33. Europe Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2027–2032
 Table 34. Europe Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Sumatriptan Subcutaneous Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Sumatriptan Subcutaneous Injection Sales by Region (K Units), 2021–2026
 Table 38. Asia Pacific Sumatriptan Subcutaneous Injection Sales by Region (K Units), 2027–2032
 Table 39. Asia Pacific Sumatriptan Subcutaneous Injection Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Sumatriptan Subcutaneous Injection Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Sumatriptan Subcutaneous Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2021–2026
 Table 43. Latin America Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2027–2032
 Table 44. Latin America Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Sumatriptan Subcutaneous Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2021–2026
 Table 48. Middle East and Africa Sumatriptan Subcutaneous Injection Sales by Country (K Units), 2027–2032
 Table 49. Middle East and Africa Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Sumatriptan Subcutaneous Injection Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Sumatriptan Subcutaneous Injection Sales (K Units) by Type (2021–2026)
 Table 52. Global Sumatriptan Subcutaneous Injection Sales (K Units) by Type (2027–2032)
 Table 53. Global Sumatriptan Subcutaneous Injection Sales Market Share by Type (2021–2026)
 Table 54. Global Sumatriptan Subcutaneous Injection Sales Market Share by Type (2027–2032)
 Table 55. Global Sumatriptan Subcutaneous Injection Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Sumatriptan Subcutaneous Injection Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Sumatriptan Subcutaneous Injection Revenue Market Share by Type (2021–2026)
 Table 58. Global Sumatriptan Subcutaneous Injection Revenue Market Share by Type (2027–2032)
 Table 59. Global Sumatriptan Subcutaneous Injection Price (US$/Unit) by Type (2021–2026)
 Table 60. Global Sumatriptan Subcutaneous Injection Price (US$/Unit) by Type (2027–2032)
 Table 61. Global Sumatriptan Subcutaneous Injection Sales (K Units) by Application (2021–2026)
 Table 62. Global Sumatriptan Subcutaneous Injection Sales (K Units) by Application (2027–2032)
 Table 63. Global Sumatriptan Subcutaneous Injection Sales Market Share by Application (2021–2026)
 Table 64. Global Sumatriptan Subcutaneous Injection Sales Market Share by Application (2027–2032)
 Table 65. Global Sumatriptan Subcutaneous Injection Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Sumatriptan Subcutaneous Injection Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Sumatriptan Subcutaneous Injection Revenue Market Share by Application (2021–2026)
 Table 68. Global Sumatriptan Subcutaneous Injection Revenue Market Share by Application (2027–2032)
 Table 69. Global Sumatriptan Subcutaneous Injection Price (US$/Unit) by Application (2021–2026)
 Table 70. Global Sumatriptan Subcutaneous Injection Price (US$/Unit) by Application (2027–2032)
 Table 71. GlaxoSmithKline Company Information
 Table 72. GlaxoSmithKline Description and Business Overview
 Table 73. GlaxoSmithKline Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 74. GlaxoSmithKline Sumatriptan Subcutaneous Injection Product
 Table 75. GlaxoSmithKline Recent Developments/Updates
 Table 76. Dr Reddy's Laboratories Company Information
 Table 77. Dr Reddy's Laboratories Description and Business Overview
 Table 78. Dr Reddy's Laboratories Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 79. Dr Reddy's Laboratories Sumatriptan Subcutaneous Injection Product
 Table 80. Dr Reddy's Laboratories Recent Developments/Updates
 Table 81. Sun Pharmaceutical Industries Company Information
 Table 82. Sun Pharmaceutical Industries Description and Business Overview
 Table 83. Sun Pharmaceutical Industries Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 84. Sun Pharmaceutical Industries Sumatriptan Subcutaneous Injection Product
 Table 85. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 86. Lupin Laboratories Company Information
 Table 87. Lupin Laboratories Description and Business Overview
 Table 88. Lupin Laboratories Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 89. Lupin Laboratories Sumatriptan Subcutaneous Injection Product
 Table 90. Lupin Laboratories Recent Developments/Updates
 Table 91. Prasco Laboratories Company Information
 Table 92. Prasco Laboratories Description and Business Overview
 Table 93. Prasco Laboratories Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 94. Prasco Laboratories Sumatriptan Subcutaneous Injection Product
 Table 95. Prasco Laboratories Recent Developments/Updates
 Table 96. Sawai Pharmaceutical Company Information
 Table 97. Sawai Pharmaceutical Description and Business Overview
 Table 98. Sawai Pharmaceutical Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 99. Sawai Pharmaceutical Sumatriptan Subcutaneous Injection Product
 Table 100. Sawai Pharmaceutical Recent Developments/Updates
 Table 101. Aurobindo Pharma Company Information
 Table 102. Aurobindo Pharma Description and Business Overview
 Table 103. Aurobindo Pharma Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 104. Aurobindo Pharma Sumatriptan Subcutaneous Injection Product
 Table 105. Aurobindo Pharma Recent Developments/Updates
 Table 106. Teva Pharmaceutical Industries Company Information
 Table 107. Teva Pharmaceutical Industries Description and Business Overview
 Table 108. Teva Pharmaceutical Industries Sumatriptan Subcutaneous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 109. Teva Pharmaceutical Industries Sumatriptan Subcutaneous Injection Product
 Table 110. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 111. Key Raw Materials Lists
 Table 112. Raw Materials Key Suppliers Lists
 Table 113. Sumatriptan Subcutaneous Injection Distributors List
 Table 114. Sumatriptan Subcutaneous Injection Customers List
 Table 115. Sumatriptan Subcutaneous Injection Market Trends
 Table 116. Sumatriptan Subcutaneous Injection Market Drivers
 Table 117. Sumatriptan Subcutaneous Injection Market Challenges
 Table 118. Sumatriptan Subcutaneous Injection Market Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sumatriptan Subcutaneous Injection
 Figure 2. Global Sumatriptan Subcutaneous Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Sumatriptan Subcutaneous Injection Market Share by Type: 2025 & 2032
 Figure 4. Prefilled Syringe Product Picture
 Figure 5. Auto-injector Device Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Sumatriptan Subcutaneous Injection Market Value by Dose Strength (US$ Million), 2021–2032
 Figure 8. Global Sumatriptan Subcutaneous Injection Market Share by Dose Strength: 2025 vs 2032
 Figure 9. 6 mg / 0.5 mL Product Picture
 Figure 10. 3 mg / 0.5 mL Product Picture
 Figure 11. Global Sumatriptan Subcutaneous Injection Market Value by Application (US$ Million), 2021–2032
 Figure 12. Global Sumatriptan Subcutaneous Injection Market Share by Application: 2025 & 2032
 Figure 13. Hospital
 Figure 14. Clinic
 Figure 15. Others
 Figure 16. Global Sumatriptan Subcutaneous Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Sumatriptan Subcutaneous Injection Market Size (US$ Million), 2021–2032
 Figure 18. Global Sumatriptan Subcutaneous Injection Sales (K Units), 2021–2032
 Figure 19. Global Sumatriptan Subcutaneous Injection Average Price (US$/Unit), 2021–2032
 Figure 20. Sumatriptan Subcutaneous Injection Report Years Considered
 Figure 21. Sumatriptan Subcutaneous Injection Sales Share by Manufacturers in 2025
 Figure 22. Global Sumatriptan Subcutaneous Injection Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Sumatriptan Subcutaneous Injection Players: Market Share by Revenue in Sumatriptan Subcutaneous Injection in 2025
 Figure 24. Sumatriptan Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Sumatriptan Subcutaneous Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Sumatriptan Subcutaneous Injection Sales Market Share by Country (2021–2032)
 Figure 27. North America Sumatriptan Subcutaneous Injection Revenue Market Share by Country (2021–2032)
 Figure 28. United States Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Sumatriptan Subcutaneous Injection Sales Market Share by Country (2021–2032)
 Figure 31. Europe Sumatriptan Subcutaneous Injection Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Sumatriptan Subcutaneous Injection Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Sumatriptan Subcutaneous Injection Revenue Market Share by Region (2021–2032)
 Figure 39. China Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. China Taiwan Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Southeast Asia Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Sumatriptan Subcutaneous Injection Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Sumatriptan Subcutaneous Injection Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Colombia Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Sumatriptan Subcutaneous Injection Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Sumatriptan Subcutaneous Injection Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Sumatriptan Subcutaneous Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Sumatriptan Subcutaneous Injection by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Sumatriptan Subcutaneous Injection by Type (2021–2032)
 Figure 59. Global Sumatriptan Subcutaneous Injection Price (US$/Unit) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Sumatriptan Subcutaneous Injection by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Sumatriptan Subcutaneous Injection by Application (2021–2032)
 Figure 62. Global Sumatriptan Subcutaneous Injection Price (US$/Unit) by Application (2021–2032)
 Figure 63. Sumatriptan Subcutaneous Injection Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS